A single point mutation in E2 enhances hepatitis C virus infectivity and alters lipoprotein association of viral particles

Virology

Volumn 395, Issue 1, 2009, Pages 67-76

  Tao, Wanyin ^a   Xu, Chunliang ^a   Ding, Qiang ^a   Li, Rui ^a   Xiang, Yu ^a   Chung, Josan ^b   Zhong, Jin ^a  

^a INSTITUTE PASTEUR OF SHANGHAI   (China)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

E2 glycoprotein; Hepatitis C virus; Infectivity; Lipoprotein

Indexed keywords

CD81 ANTIGEN; GLYCOPROTEIN E2; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; NEUTRALIZING ANTIBODY; RECOMBINANT PROTEIN; VERY LOW DENSITY LIPOPROTEIN; VIRUS RECEPTOR; VIRUS RNA;

ARTICLE; GENETIC TRANSFECTION; HEPATITIS C VIRUS; HUMAN CELL CULTURE; IMMUNOFLUORESCENCE; IN VITRO STUDY; LIFE CYCLE; MOLECULAR CLONING; NONHUMAN; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; RNA ANALYSIS; RNA INTERFERENCE; VIRUS ENTRY; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS TITRATION; VIRUS TRANSCRIPTION;

ANTIBODIES, NEUTRALIZING; ANTIGENS, CD; CELL LINE; HEPACIVIRUS; HEPATITIS C; HUMANS; LIPOPROTEINS, LDL; POINT MUTATION; RNA, VIRAL; VIRAL ENVELOPE PROTEINS; VIRION; VIRUS INTERNALIZATION;

HEPATITIS C VIRUS;

EID: 71749087885     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.09.006     Document Type: Article

References (43)

1. Agnello V., Abel G., Elfahal M., Knight G.B., and Zhang Q.X. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc. Natl. Acad. Sci. U. S. A. 96 22 (1999) 12766-12771
2. Akazawa D., Date T., Morikawa K., Murayama A., Omi N., Takahashi H., Nakamura N., Ishii K., Suzuki T., Mizokami M., Mochizuki H., and Wakita T. Characterization of infectious hepatitis C virus from liver-derived cell lines. Biochem. Biophys. Res. Commun. 377 3 (2008) 747-751
3. Bartenschlager R., and Lohmann V. Replication of hepatitis C virus. J. Gen. Virol. 81 Pt 7 (2000) 1631-1648
4. Barth H., Schafer C., Adah M.I., Zhang F., Linhardt R.J., Toyoda H., Kinoshita-Toyoda A., Toida T., Van Kuppevelt T.H., Depla E., Von Weizsacker F., Blum H.E., and Baumert T.F. Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate. J. Biol. Chem. 278 42 (2003) 41003-41012
5. Bartosch B., Vitelli A., Granier C., Goujon C., Dubuisson J., Pascale S., Scarselli E., Cortese R., Nicosia A., and Cosset F.L. Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. J. Biol. Chem. 278 43 (2003) 41624-41630
6. Burlone M.E., and Budkowska A. Hepatitis C virus cell entry: role of lipoproteins and cellular receptors. J. Gen. Virol. 90 Pt 5 (2009) 1055-1070
7. Chang K.S., Jiang J., Cai Z., and Luo G. Human apolipoprotein e is required for infectivity and production of hepatitis C virus in cell culture. J. Virol. 81 24 (2007) 13783-13793
8. Date T., Miyamoto M., Kato T., Morikawa K., Murayama A., Akazawa D., Tanabe J., Sone S., Mizokami M., and Wakita T. An infectious and selectable full-length replicon system with hepatitis C virus JFH-1 strain. Hepatol. Res. 37 6 (2007) 433-443
9. Delgrange D., Pillez A., Castelain S., Cocquerel L., Rouille Y., Dubuisson J., Wakita T., Duverlie G., and Wychowski C. Robust production of infectious viral particles in Huh-7 cells by introducing mutations in hepatitis C virus structural proteins. J. Gen. Virol. 88 Pt 9 (2007) 2495-2503
10. Dreux M., Boson B., Ricard-Blum S., Molle J., Lavillette D., Bartosch B., Pecheur E.I., and Cosset F.L. The exchangeable apolipoprotein ApoC-I promotes membrane fusion of hepatitis C virus. J. Biol. Chem. 282 44 (2007) 32357-32369
11. Drummer H.E., Wilson K.A., and Poumbourios P. Identification of the hepatitis C virus E2 glycoprotein binding site on the large extracellular loop of CD81. J. Virol. 76 21 (2002) 11143-11147
12. Evans M.J., von Hahn T., Tscherne D.M., Syder A.J., Panis M., Wolk B., Hatziioannou T., McKeating J.A., Bieniasz P.D., and Rice C.M. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446 7137 (2007) 801-805
13. Gastaminza P., Cheng G., Wieland S., Zhong J., Liao W., and Chisari F.V. Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion. J. Virol. 82 5 (2008) 2120-2129
14. Grove J., Huby T., Stamataki Z., Vanwolleghem T., Meuleman P., Farquhar M., Schwarz A., Moreau M., Owen J.S., Leroux-Roels G., Balfe P., and McKeating J.A. Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity. J. Virol. 81 7 (2007) 3162-3169
15. Grove J., Nielsen S., Zhong J., Bassendine M.F., Drummer H.E., Balfe P., and McKeating J.A. Identification of a residue in hepatitis C virus E2 glycoprotein that determines scavenger receptor BI and CD81 receptor dependency and sensitivity to neutralizing antibodies. J. Virol. 82 24 (2008) 12020-12029
16. Hsu M., Zhang J., Flint M., Logvinoff C., Cheng-Mayer C., Rice C.M., and McKeating J.A. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc. Natl. Acad. Sci. U. S. A. 100 12 (2003) 7271-7276
17. Huang H., Sun F., Owen D.M., Li W., Chen Y., Gale Jr. M., and Ye J. Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins. Proc. Natl. Acad. Sci. U. S. A. 104 14 (2007) 5848-5853
18. Kapadia S.B., Barth H., Baumert T., McKeating J.A., and Chisari F.V. Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I. J. Virol. 81 1 (2007) 374-383
19. Kato T., Date T., Miyamoto M., Furusaka A., Tokushige K., Mizokami M., and Wakita T. Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology 125 6 (2003) 1808-1817
20. Kaul A., Woerz I., Meuleman P., Leroux-Roels G., and Bartenschlager R. Cell culture adaptation of hepatitis C virus and in vivo viability of an adapted variant. J. Virol. 81 23 (2007) 13168-13179
21. Koutsoudakis G., Kaul A., Steinmann E., Kallis S., Lohmann V., Pietschmann T., and Bartenschlager R. Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses. J. Virol. 80 11 (2006) 5308-5320
22. Koutsoudakis G., Herrmann E., Kallis S., Bartenschlager R., and Pietschmann T. The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells. J. Virol. 81 2 (2007) 588-598
23. Lauer G.M., and Walker B.D. Hepatitis C virus infection. N. Engl. J. Med. 345 1 (2001) 41-52
24. Law M., Maruyama T., Lewis J., Giang E., Tarr A.W., Stamataki Z., Gastaminza P., Chisari F.V., Jones I.M., Fox R.I., Ball J.K., McKeating J.A., Kneteman N.M., and Burton D.R. Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge. Nat. Med. 14 1 (2008) 25-27
25. Liu S., Yang W., Shen L., Turner J.R., Coyne C.B., and Wang T. Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection. J. Virol. 83 4 (2009) 2011-2014
26. Meunier J.C., Engle R.E., Faulk K., Zhao M., Bartosch B., Alter H., Emerson S.U., Cosset F.L., Purcell R.H., and Bukh J. Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1. Proc. Natl. Acad. Sci. U. S. A. 102 12 (2005) 4560-4565
27. Meunier J.C., Russell R.S., Engle R.E., Faulk K.N., Purcell R.H., and Emerson S.U. Apolipoprotein c1 association with hepatitis C virus. J. Virol. 82 19 (2008) 9647-9656
28. Molina S., Castet V., Fournier-Wirth C., Pichard-Garcia L., Avner R., Harats D., Roitelman J., Barbaras R., Graber P., Ghersa P., Smolarsky M., Funaro A., Malavasi F., Larrey D., Coste J., Fabre J.M., Sa-Cunha A., and Maurel P. The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus. J. Hepatol. 46 3 (2007) 411-419
29. Monazahian M., Kippenberger S., Muller A., Seitz H., Bohme I., Grethe S., and Thomssen R. Binding of human lipoproteins (low, very low, high density lipoproteins) to recombinant envelope proteins of hepatitis C virus. Med. Microbiol. Immunol. 188 4 (2000) 177-184
30. Nahmias Y., Goldwasser J., Casali M., van Poll D., Wakita T., Chung R.T., and Yarmush M.L. Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin. Hepatology 47 5 (2008) 1437-1445
31. Op De Beeck A., Cocquerel L., and Dubuisson J. Biogenesis of hepatitis C virus envelope glycoproteins. J. Gen. Virol. 82 Pt 11 (2001) 2589-2595
32. Pileri P., Uematsu Y., Campagnoli S., Galli G., Falugi F., Petracca R., Weiner A.J., Houghton M., Rosa D., Grandi G., and Abrignani S. Binding of hepatitis C virus to CD81. Science 282 5390 (1998) 938-941
33. Ploss A., Evans M.J., Gaysinskaya V.A., Panis M., You H., de Jong Y.P., and Rice C.M. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 457 7231 (2009) 882-886
34. Rubinson D.A., Dillon C.P., Kwiatkowski A.V., Sievers C., Yang L., Kopinja J., Rooney D.L., Zhang M., Ihrig M.M., McManus M.T., Gertler F.B., Scott M.L., and Van Parijs L. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. 33 3 (2003) 401-406
35. Russell R.S., Meunier J.C., Takikawa S., Faulk K., Engle R.E., Bukh J., Purcell R.H., and Emerson S.U. Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus. Proc. Natl. Acad. Sci. U. S. A. 105 11 (2008) 4370-4375
36. Saunier B., Triyatni M., Ulianich L., Maruvada P., Yen P., and Kohn L.D. Role of the asialoglycoprotein receptor in binding and entry of hepatitis C virus structural proteins in cultured human hepatocytes. J. Virol. 77 1 (2003) 546-559
37. Scarselli E., Ansuini H., Cerino R., Roccasecca R.M., Acali S., Filocamo G., Traboni C., Nicosia A., Cortese R., and Vitelli A. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J. 21 19 (2002) 5017-5025
38. Thomssen R., Bonk S., Propfe C., Heermann K.H., Kochel H.G., and Uy A. Association of hepatitis C virus in human sera with beta-lipoprotein. Med. Microbiol. Immunol. 181 5 (1992) 293-300
39. Tscherne D.M., Jones C.T., Evans M.J., Lindenbach B.D., McKeating J.A., and Rice C.M. Time-and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry. J. Virol. 80 4 (2006) 1734-1741
40. Voisset C., Callens N., Blanchard E., Op De Beeck A., Dubuisson J., and Vu-Dac N. High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I. J. Biol. Chem. 280 9 (2005) 7793-7799
41. Zeisel M.B., Koutsoudakis G., Schnober E.K., Haberstroh A., Blum H.E., Cosset F.L., Wakita T., Jaeck D., Doffoel M., Royer C., Soulier E., Schvoerer E., Schuster C., Stoll-Keller F., Bartenschlager R., Pietschmann T., Barth H., and Baumert T.F. Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81. Hepatology 46 6 (2007) 1722-1731
42. Zhong J., Gastaminza P., Cheng G., Kapadia S., Kato T., Burton D.R., Wieland S.F., Uprichard S.L., Wakita T., and Chisari F.V. Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. U. S. A. 102 26 (2005) 9294-9299
43. Zhong J., Gastaminza P., Chung J., Stamataki Z., Isogawa M., Cheng G., McKeating J.A., and Chisari F.V. Persistent hepatitis C virus infection in vitro: coevolution of virus and host. J. Virol. 80 22 (2006) 11082-11093